Articles tagged with Rma

Showing 15 of 174 articles

Chanel Invests in New Zealand’s Lammermoor Station to Boost Premium Wool Exports

22 Apr 2026 | 4 months ago | 921 views

The New Zealand Government has welcomed Chanel’s investment in Lammermoor Station, a premium organic fine wool producer, highlighting it as a boost to the country’s export growth and job retention. Recent reforms have significantly streamlined overseas investment application processes, reducing approval times and increasing investor confidence. Chanel aims to enhance Lammermoor’s status by pursuing Regenerative Organic Certification, which would further elevate the value and reputation of New Zealand’s sustainable wool industry.

Tags: Chanel David Seymour Nicola Willis Mike Butterick Lammermoor Station New Zealand Land Information New Zealand Regenerative Organic Certification Overseas Investment Act French luxury fashion

Easier, Affordable Kids’ Health Treatment via Community Pharmacies in NZ from June

15 Apr 2026 | 4 months ago | 953 views

From June, New Zealand will expand funded treatment services through community pharmacies to provide easier and more affordable care for children’s common health conditions, reducing reliance on GP appointments. Pharmacists will be authorized to assess patients and supply subsidized medicines for issues like pain, fever, scabies, and urinary tract infections, supported by a $5 million annual fund to ensure nationwide availability. This initiative aims to improve timely access to healthcare, especially in rural and underserved areas, by leveraging pharmacists as accessible and trusted health professionals.

Tags: Simeon Brown David Seymour Health New Zealand Pharmacists community pharmacies GP appointments Extended Pharmacy Services Fund Pharmaceutical Schedule New Zealand health children's healthcare

NZ Expands Cancer Infusion Services Nationwide for Faster, Local Treatment

12 Apr 2026 | 4 months ago | 934 views

New Zealand is expanding community infusion services with 14 new centres and 14 expansions to provide thousands more cancer treatments closer to patients’ homes, supported by a $210 million investment from Budget 2024. This initiative responds to a 12% increase in demand, adding 218 more chair-days weekly and addressing the need for increased capacity following the introduction of 33 new cancer medicines funded by Pharmac. The government aims to improve cancer outcomes by ensuring timely, accessible treatment nationwide, while recruiting additional healthcare staff to support the expanded services through 2028.

Tags: Simeon Brown Pharmac Budget 2024 New Zealand cancer treatment infusion centres community infusion services healthcare expansion cancer care medical workforce

New Zealand Eases EV Charger Consenting with National Permitted Activity Standards

08 Apr 2026 | 5 months ago | 938 views

The New Zealand Government has amended the National Environmental Standards for Electricity Transmission Activities (NES-ETA) to introduce nationally consistent permitted activity standards for electric vehicle (EV) charging infrastructure, removing confusing local consenting barriers and making it easier to build chargers. These changes, effective from 7 May 2026, cover all types of EV chargers and include conditions to manage environmental and community effects, while complementing a $52.7 million investment to expand the public charging network from 1,800 to an expected 4,550 points. This reform aims to accelerate EV adoption by simplifying infrastructure development, supporting the Government’s goal of 10,000 chargers by 2030, and aligning with broader resource management and planning system improvements.

Tags: Chris Bishop New Zealand electric vehicle EV charging infrastructure Resource Management Act ChargeNet Meridian National Environmental Standards RMA Reform Minister

Pharmac Funds New Combination Therapies for Chronic Lymphocytic Leukaemia in NZ

08 Apr 2026 | 5 months ago | 876 views

Associate Health Minister David Seymour applauds Pharmac’s decision to fund two new combination therapies—venetoclax with ibrutinib or obinutuzumab—as first-line treatments for chronic lymphocytic leukaemia (CLL), along with expanded access to ibrutinib as a second-line option. These treatments, available from May 2026, aim to improve patient outcomes by enabling longer remission, reducing the need for chemotherapy and hospital visits, and accommodating patient feedback gathered through community consultation. Since the government increased Pharmac’s budget, over 200,000 patients have benefited from funding decisions on 133 medicines, including 46 cancer treatments, reflecting a more collaborative approach with the patient community.

Tags: David Seymour Pharmac chronic lymphocytic leukaemia CLL venetoclax ibrutinib obinutuzumab cancer medication New Zealand cancer patients

New Zealand and Cook Islands Sign Historic Defence & Security Declaration

01 Apr 2026 | 5 months ago | 834 views

New Zealand and the Cook Islands have signed a Defence & Security Declaration to clarify and strengthen their special constitutional relationship, particularly regarding defence and security responsibilities amid a complex strategic environment. The Declaration resolves previous misunderstandings, restores New Zealand’s financial support to the Cook Islands, and establishes mutual commitments including consultation on defence matters, New Zealand’s role as the primary security partner, and cooperation on foreign policy within constitutional limits. Both nations have agreed not to engage with other partners in ways that would undermine these commitments, aiming to enhance their partnership and address shared challenges together.

Tags: New Zealand Cook Islands Winston Peters Norman Kirk Albert Henry Prime Minister Brown Defence & Security Declaration free association New Zealand Defence Force Letters Patent

New Public Finance Amendment Act Enhances Fiscal Transparency in NZ

31 Mar 2026 | 5 months ago | 905 views

New legislation requires the Treasury to include specific fiscal risk statements in economic and fiscal updates, addressing previously unclear risks such as time-limited funding for Pharmac medicines. The Act removes the requirement for Treasury to report on wellbeing, focusing instead on core economic and fiscal advice, and advances the delivery date of the Pre-Election Economic and Fiscal Update by five working days to better inform voters. This law will take effect on July 1, 2026.

Tags: Nicola Willis Public Finance Amendment Act Treasury Pharmac PREFU New Zealand Finance Minister Parliament fiscal risks

New Public Finance Amendment Act Enhances Fiscal Transparency in NZ

31 Mar 2026 | 5 months ago | 798 views

New legislation requires the Treasury's economic and fiscal updates to include specific statements on fiscal risks, addressing previous omissions like time-limited funding for essential medicines. It also removes the Treasury's obligation to report on "wellbeing," refocusing its role on core economic and fiscal advice, and advances the delivery date of the Pre-Election Economic and Fiscal Update to give voters more time to consider election choices. The Act is set to take effect by July 1, 2026.

Tags: Nicola Willis Public Finance Amendment Act Treasury Pharmac New Zealand PREFU Finance Minister Parliament fiscal risks economic outlook

Pharmac Expands Funding for Trikafta, Alyftrek & Kalydeco for All Children with Cystic Fibrosis

31 Mar 2026 | 5 months ago | 913 views

Associate Health Minister David Seymour welcomes Pharmac’s decision to fund Trikafta and Alyftrek for all children with cystic fibrosis regardless of age from April 1, 2026, expanding access beyond the previous age limits. Pharmac will also widen access to Kalydeco for all eligible patients and allow doctors to prescribe these lifechanging treatments based on clinical judgment, addressing the urgent needs of young children affected by cystic fibrosis. This decision follows positive public consultation and reflects Pharmac’s commitment to working with the cystic fibrosis community to improve health outcomes and reduce pressure on the health system.

Tags: David Seymour Pharmac Trikafta Alyftrek Kalydeco cystic fibrosis children health minister New Zealand funding decision

Government Lowers Auckland Housing Capacity Target to 1.4 Million Homes

30 Mar 2026 | 5 months ago | 1015 views

The Government will introduce legislation to amend the Resource Management Act, reducing Auckland Council’s Plan Change 120 minimum housing capacity from 2 million to 1.4 million homes while still supporting significant growth through upzoning and infrastructure-aligned development. The legislation also resolves transitional issues for developers affected by previous rule changes and aims to enable further housing opportunities, particularly around transit corridors and the City Rail Link. Auckland Council will revise the plan based on guiding principles, and the updated process will allow public input before final decisions are made.

Tags: Chris Bishop Auckland Council Plan Change 120 Resource Management Act Housing and RMA Reform Auckland housing National Policy Statement on Urban Development City Rail Link Medium Density Residential Standards Auckland Unitary Plan

Pharmac's Deal with Medtronic to Save $1.2M Annually on Drug-Eluting Stents

26 Mar 2026 | 5 months ago | 950 views

Pharmac has proposed a provisional agreement with Medtronic New Zealand to supply 65% of drug-eluting stents to public hospitals, potentially saving $1.2 million annually while ensuring access to high-quality stents. The proposal, developed with input from the Interventional Cardiology Advisory Group, aims to improve procurement efficiency and collaboration between Pharmac and Health New Zealand. Public consultation is open until April 28 to gather feedback from healthcare professionals and stakeholders before finalizing the deal for implementation starting June 2026.

Tags: David Seymour Pharmac Medtronic New Zealand Health New Zealand Interventional Cardiology Advisory Group Associate Health Minister public hospitals Principal Supply Status Pharmaceutical Schedule

Attorney-General Appoints Two New District Court Judges for Palmerston North and Nelson

20 Mar 2026 | 5 months ago | 1009 views

Attorney-General Judith Collins announced the appointment of Prudence McGuire and Christopher Macklin as new District Court Judges, to commence their roles in April and May 2026 at Palmerston North and Nelson Courts, respectively. Ms. McGuire, a Rotorua-based barrister with extensive experience in family and criminal law, will be sworn in on 21 April 2026, while Mr. Macklin, a Nelson-based barrister specializing in criminal and regulatory litigation, will be sworn in on 15 May 2026. Both appointees have significant legal backgrounds, including prosecutorial roles and leadership positions within the legal community.

Tags: Judith Collins Prudence McGuire Christopher Macklin LW Goodman Wollerman Cooke McClure Davys Burton Russell McVeagh Gordon and Pilditch NZLS Criminal Law Committee Palmerston North District Court

Government Allocates $50M for New Geothermal Projects to Boost Regional Growth

17 Mar 2026 | 5 months ago | 954 views

The New Zealand Government has ringfenced $50 million from the Regional Infrastructure Fund to support early-stage geothermal projects, aiming to de-risk exploration and boost regional productivity and resilience. So far, three projects have received funding, including two $10 million loans for the Taumanu and Kopura geothermal projects and a $3 million grant for the Whakatāne Geothermal Temperature Gradient Well Programme. These initiatives are expected to create jobs, promote Māori economic development, and enhance renewable energy capacity through exploration and potential new geothermal power stations.

Tags: Shane Jones Taumanu Kopura Eastland Generation Māori University of Auckland Geothermal Institute Whakatāne Regional Infrastructure Fund Bay of Plenty

New Zealand’s Geothermal Strategy Aims to Double Energy Use by 2040

17 Mar 2026 | 5 months ago | 1005 views

The Government has launched the "From the Ground Up" strategy to double geothermal energy use by 2040, aiming to boost investment, modernize regulations, and support both traditional and next-generation geothermal technologies. The plan emphasizes regional economic growth, Māori partnerships, and unlocking the cultural and economic value of geothermal resources. By improving development conditions and fostering innovation, the strategy seeks to enhance New Zealand's energy resilience and position it as a global leader in geothermal power.

Tags: Shane Jones New Zealand Geothermal Rotorua Ngāwhā Kawerau Taupō Māori Resources Minister From the Ground Up

Government to Shift Ambulance Medicine Funding to Pharmac for Better Care and Savings

11 Mar 2026 | 6 months ago | 956 views

The Government plans to transfer funding responsibility for ambulance medicines from Health New Zealand and ACC to Pharmac to improve procurement efficiency, ensure nationwide access to consistent emergency medicines, and save costs. This change will create a single nationally consistent medicine list for ambulance services, enhancing continuity of care between ambulance providers and hospitals while leveraging Pharmac’s expertise and buying power. Public consultation on the proposal is open from March 12 to April 2, 2024, with implementation targeted for July 1, 2026.

Tags: David Seymour Simeon Brown Pharmac Health New Zealand ACC ambulance medicines emergency care medicine procurement New Zealand government pharmaceutical schedule